nose
orific
breath
filter
moistur
regul
temperatur
air
enter
nose
pharynx
lung
provid
olfact
divid
two
compart
nasal
septum
short
somewhat
stiff
sensit
hair
locat
nasal
entranc
allow
enhanc
tactil
stimuli
result
nasal
itch
sneez
superior
middl
inferior
turbin
extend
later
wall
side
nose
occupi
much
free
space
within
nasal
caviti
overli
superior
middl
inferior
nasal
meatu
respect
becom
edemat
variou
form
rhiniti
rhinosinus
subsequ
obstruct
airflow
middl
meatu
import
contain
three
convolut
narrow
ostiomeat
pathway
drain
anterior
ethmoid
frontal
maxillari
sinus
sever
kind
epitheli
cell
line
nasal
caviti
sinus
stratifi
squamou
epithelium
locat
distal
vestibul
nose
continu
facial
skin
nasal
caviti
sinus
respiratori
tract
line
respiratori
epithelium
contain
variou
cell
type
includ
ciliat
columnar
goblet
cell
goblet
cell
locat
within
epithelium
produc
mucu
mobil
clear
ciliat
columnar
epitheli
cell
special
olfactori
ciliat
epithelium
locat
superior
aspect
nose
epitheli
line
nasal
caviti
constant
contact
extern
environ
regularli
expos
chang
ambient
temperatur
humid
allergen
infecti
agent
pollut
airborn
substanc
amount
blood
reach
nose
nasal
pharynx
control
constrict
dilat
small
arteri
arteriol
depend
physiolog
environment
influenc
subepitheli
capillari
fenestr
make
capabl
respond
rapidli
administr
intranas
medic
olfactori
nerv
branch
trigemin
nerv
ophthalm
maxillari
branch
innerv
nasal
caviti
sympathet
parasympathet
nerv
fiber
caus
vasoconstrict
vasodilat
respect
appropri
stimul
paranas
sinu
caviti
contain
air
commun
nasal
caviti
via
ostia
approxim
ml
diamet
goblet
cell
line
sinus
produc
nitric
oxid
vasodilatori
antimicrobi
properti
exact
function
sinus
remain
unknown
pair
sinus
depend
respect
ostiomeat
complex
ventil
mucu
drainag
obstruct
complex
result
increas
decreas
sinu
pressur
place
affect
subject
risk
develop
acut
chronic
rhinosinus
pneumat
sinus
begin
birth
complet
adolesc
degre
pneumat
vari
sphenoid
frontal
sinus
last
develop
normal
individu
frontal
sinus
anterior
posterior
ethmoid
sinus
situat
medial
orbit
bilater
drain
middl
superior
meatu
respect
maxillari
sinus
lie
later
nose
side
face
maxilla
orbit
drain
middl
meatu
pair
frontal
sinus
aris
within
frontal
bone
drain
middl
meatu
sphenoid
sinus
lie
posterior
ethmoid
cell
drain
sphenoethmoid
recess
either
side
posterior
nasal
septum
superior
superior
nasal
concha
fig
primari
function
upper
airway
epithelium
warm
cool
humidifi
air
defend
host
noxiou
agent
includ
pollut
allergen
infecti
agent
allerg
rhiniti
caus
allerg
immun
respons
specif
ige
antibodi
combin
allergen
subject
allerg
caus
hypersensit
reaction
reaction
also
refer
type
hypersensit
reaction
atop
subject
famili
histori
atop
eczema
allerg
rhinoconjunct
allerg
asthma
therefor
genet
predispos
develop
diseas
ige
principl
mediat
immedi
hypersensit
reaction
attach
mast
cell
present
blood
vessel
connect
tissu
mucos
membran
nonatop
subject
also
produc
ige
mast
cell
howev
genet
predisposit
famili
histori
allergen
exposur
atop
subject
becom
sensit
specif
allergen
expos
allergen
allerg
develop
immedi
hypersensit
reaction
caus
acut
chronic
allerg
rhinosinus
allerg
asthma
viral
infect
environment
pollut
thought
play
role
sensit
process
exampl
allerg
reaction
catallerg
subject
develop
allerg
rhiniti
expos
cat
allergen
aerosol
cat
saliva
pelt
protein
sourc
cat
allergen
inhal
allergen
absorb
onto
mucos
surfac
case
nose
two
ige
molecul
locat
mast
cell
bridg
cat
allergen
trigger
mast
cell
releas
store
newli
gener
vasoact
amin
histamin
proteas
also
gener
secret
product
arachidon
acid
prostaglandin
leukotrien
cytokin
tumor
necrosi
factor
tnf
mediat
caus
inflammatori
respons
vascular
dilat
increas
vascular
permeabl
recruit
eosinophil
neutrophil
cell
fig
b
also
caus
smooth
muscl
contract
bronchi
respons
bronchial
constrict
introduc
via
inhal
process
antigenpres
cell
apc
allergen
degrad
small
amino
acid
chain
subsequ
display
major
histocompat
complex
ii
mhc
ii
specif
tcell
receptor
tcr
recognit
specif
tcr
recogn
process
allergen
mhc
ii
seri
event
occur
lead
tcell
activ
activ
cell
interact
specif
b
cell
becom
activ
activ
b
cell
help
interleukin
undergo
immunoglobulin
class
switch
classswitch
b
cell
becom
plasma
cell
begin
produc
immunoglobulin
e
ige
specif
allergen
secret
ige
coat
mast
cell
b
upon
reexposur
ident
allergen
ige
attach
mast
cell
via
highaffin
ige
receptor
recogn
allergen
crosslink
ige
molecul
crosslink
lead
mast
cell
degranul
secret
store
newli
form
inflammatori
mediat
eg
histamin
heparin
prostaglandin
pg
variou
cytokin
mediat
respons
earlyand
latephas
sign
symptom
igemedi
allerg
diseas
allerg
asthma
inflammatori
cascad
trigger
symptom
allerg
rhiniti
includ
sneez
nasal
itch
rhinorrhea
nasal
congest
asthma
inflamm
caus
cough
wheez
short
breath
inflammatori
process
ultim
damag
epitheli
tissu
nose
sinus
lung
symptom
rhiniti
rhinosinus
chang
pregnanc
subject
improv
worsen
other
remain
one
five
pregnant
women
may
affect
allerg
rhiniti
allerg
asthma
atop
eczema
combin
thereof
addit
incid
type
rhiniti
exampl
nonallerg
rhiniti
may
increas
due
physiolog
hormon
chang
associ
pregnanc
pregnancyassoci
hormon
effect
nasal
blood
flow
mucos
gland
caus
edema
hyperemia
nasal
mucosa
result
rhiniti
pregnanc
epistaxi
worsen
underli
type
rhiniti
rhinosinus
may
present
pregnanc
occur
pregnanc
topic
discuss
rhiniti
character
presenc
one
follow
nasal
symptom
congest
anterior
posterior
rhinorrhea
sneez
pruritu
often
confus
rhinosinus
term
usual
synonym
sinus
tabl
poorli
control
rhiniti
signific
caus
impair
qualiti
life
associ
facial
discomfort
fatig
cognit
impair
sleep
disturb
appropri
manag
rhiniti
also
essenti
optim
control
asthma
sleep
apnea
variou
common
type
rhiniti
tabl
caus
inflamm
epitheli
line
nasal
caviti
occur
allerg
infecti
rhiniti
form
rhiniti
includ
rhiniti
pregnanc
atroph
rhiniti
rhiniti
medicamentosa
rhiniti
associ
system
diseas
granulomatosi
polyangi
histor
known
wegen
granulomatosi
eosinophil
granulomatosi
polyangi
churgstrauss
syndrom
diseas
also
present
subject
pregnant
consid
especi
sever
symptom
differenti
diagnosi
headach
cough
malais
note
season
legend
present
present
present
present
etiolog
allerg
rhiniti
affect
million
peopl
unit
state
approxim
children
adult
includ
onethird
women
childbear
age
becom
wors
approxim
onethird
affect
pregnant
subject
character
symptom
begin
within
minut
allergen
exposur
often
follow
latephas
respons
hour
later
earlyphas
symptom
includ
nasal
congest
sneez
rhinorrhea
pruritu
eighti
percent
subject
also
allerg
conjunct
caus
itch
red
tear
eye
congest
nose
domin
latephas
reaction
continu
allergen
exposur
result
chronic
symptom
nose
eye
affect
refer
allerg
rhinoconjunct
suspect
diagnosi
affect
conjunctiva
often
inject
accompani
chemosi
edema
bulbar
conjunctiva
appropri
prickpunctur
intraderm
skin
test
vitrospecif
ige
test
help
confirm
histor
suspect
caus
allergen
associ
diseas
vitro
test
prefer
pregnanc
manag
pregnant
versu
nonpregn
subject
significantli
differ
nonpharmacolog
strategi
allergen
irrit
avoid
import
data
safeti
rhiniti
medic
pregnanc
review
detail
chap
nonsed
secondgener
antihistamin
cetirizin
loratadin
consid
safe
first
drug
choic
montelukast
also
consid
safe
use
pregnanc
effect
persist
symptom
intranas
corticosteroid
util
mometason
beclomethason
fluticason
other
although
safeti
nasal
decongest
phenylephrin
oxymetazolin
studi
directli
appear
safe
shortterm
use
less
day
particularli
first
trimest
howev
oral
decongest
associ
birth
defect
use
first
trimest
tabl
allergen
immunotherapi
anoth
treatment
modal
allergensensit
subject
receiv
allergen
vaccin
manifest
allergi
either
subcutan
allergen
immunotherapi
scit
sublingu
allergen
immunotherapi
slit
scit
often
prescrib
multipl
allergen
involv
pathogenesi
diseas
ie
allergi
tree
grass
weed
pollen
dust
mite
cat
dog
allergen
slit
primarili
employ
number
allergen
individu
limit
eg
grass
pollen
ragwe
pollen
andor
dust
mite
given
time
therapi
induc
clinic
toler
allergen
individu
allerg
therapi
usual
begin
pregnanc
allergen
immunotherapi
depend
riskbenefit
continu
discontinu
pregnanc
scit
dose
allergen
vaccin
interv
inject
usual
halv
decreas
potenti
induc
system
allerg
reaction
affect
welfar
fetu
mother
slit
similar
scit
except
allergen
vaccin
tablet
slit
deliv
tongu
absorb
local
subcutan
rout
inform
slit
safeti
pregnanc
insuffici
anim
studi
show
risk
fetu
gener
allergen
immunotherapi
continu
toler
initi
pregnanc
etiolog
pregnanc
rhiniti
also
call
rhiniti
pregnanc
menstrual
cycl
rhiniti
exampl
hormon
induc
rhiniti
pregnanc
rhiniti
associ
nasal
congest
usual
begin
month
pregnanc
occur
approxim
randomli
select
women
principl
caus
increas
prolactin
vasoact
intestin
peptid
placent
growth
hormon
progesteron
estrogen
affect
nasal
vasculatur
result
vascular
engorg
increas
mucos
gland
activ
pregnanc
rhiniti
usual
abat
week
postpartum
diagnosi
made
clinic
adequ
histori
physic
examin
form
rhiniti
exclud
treatment
hormon
rhiniti
similar
nonallerg
rhiniti
syndrom
includ
avoid
aggrav
irrit
women
toler
symptom
pregnanc
rhiniti
without
medic
manag
howev
rhiniti
pregnanc
associ
increas
snore
possibl
place
mother
risk
sleep
apnea
exacerb
hypertens
associ
pregnanc
also
may
factor
develop
preeclampsia
treatment
may
includ
exercis
head
bed
elev
nasal
alar
dilat
nasal
salin
rins
measur
fail
intranas
corticosteroid
budesonid
administ
although
intranas
fluticason
effect
pregnanc
rhiniti
one
studi
decongest
oxymetazolin
pseudoephedrin
may
use
caution
appropri
riskbenefit
discuss
howev
administ
first
trimest
may
associ
teratogen
etiolog
infecti
rhiniti
associ
upper
respiratori
tract
infect
uri
common
cold
acut
inflammatori
diseas
upper
airway
uri
primarili
caus
acut
viral
infect
common
virus
includ
rhinoviru
coronaviru
influenza
viru
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
enteroviru
fig
incub
period
usual
h
symptom
persist
day
symptom
includ
nasal
congest
clear
mucopurul
nasal
discharg
sensat
discomfort
pressur
face
headach
olfactori
disturb
cough
postnas
drip
secondari
bacteri
infect
sometim
occur
necessit
addit
therapi
bacteri
etiolog
consid
symptom
persist
beyond
day
symptom
worsen
transient
improv
infecti
rhiniti
diagnos
clinic
base
histori
physic
examin
cultur
nasal
secret
usual
indic
accur
reflect
organ
sinus
caus
infect
treatment
viral
uri
pregnanc
ident
nonpregn
subject
subject
usual
observ
day
anticip
spontan
resolut
antibiot
usual
necessari
unless
primari
secondari
bacteri
infect
suspect
decongest
use
cautious
particularli
first
trimest
antibiot
consid
primari
secondari
bacteri
sinu
infect
includ
penicillin
deriv
includ
contain
sulbactamclavulan
cephalosporin
erythromycin
azithromycin
clindamycin
also
use
antibiot
fail
clarithromycin
fluoroquinolon
aminoglycosid
sulfonamid
tetracyclin
vancomycin
consid
first
line
especi
first
trimest
due
potenti
greater
side
effect
appropri
antibiot
use
necessari
subject
symptom
resolv
nonallerg
rhiniti
also
refer
vasomotor
idiopath
rhiniti
thought
vagal
mediat
occasion
associ
gustatori
rhiniti
ie
rhinorrhea
exacerb
eat
subject
nonallerg
rhiniti
appear
heighten
sensit
nocicept
stimuli
aerosol
irrit
spici
food
environment
temperatur
chang
alcohol
ingest
cold
dri
air
even
exercis
symptom
variabl
consist
mainli
nasal
obstruct
rhinorrhea
anteriorli
posterior
pharynx
postnas
drip
sneez
pruritu
less
common
nonallerg
rhiniti
diagnos
primarili
type
rhiniti
exclud
base
characterist
histori
physic
find
mainli
nasal
mucos
edema
trigger
exacerb
diseas
mani
women
experi
type
rhiniti
pregnanc
confus
pregnanc
rhiniti
symptomat
therapi
includ
elev
head
bed
avoid
irrit
use
intranas
salin
measur
fail
symptom
persist
pharmacolog
intervent
consid
intranas
ipratropium
bromid
primarili
use
treat
excess
nasal
secret
rhinorrhea
occur
anteriorli
posteriorli
especi
effect
gustatori
rhiniti
intranas
corticosteroid
drug
choic
eosinophil
nonallerg
rhiniti
see
tri
subject
nonallerg
rhiniti
oral
topic
antihistamin
azelastin
also
consid
although
safeti
pregnanc
studi
topic
antihistamin
azelastin
also
efficaci
studi
human
pregnanc
sometim
use
along
cautiou
use
nasal
decongest
prefer
avoid
especi
first
trimest
oxymetazolin
drop
spray
one
two
spray
nostril
twice
daili
ideal
day
row
may
help
subject
substanti
nasal
obstruct
intranas
corticosteroid
report
protect
rhiniti
medicamentosa
therefor
patient
maintain
intranas
corticosteroid
oxymetazolin
equival
use
long
term
nonallerg
rhiniti
eosinophilia
syndrom
nare
nonallerg
inflammatori
form
rhiniti
subject
perenni
symptom
includ
sneez
wateri
rhinorrhea
nasal
pruritu
congest
intermitt
decreas
olfactori
sensat
preval
etiolog
unknown
characterist
associ
eosinophilia
found
nasal
smear
greater
lack
demonstr
allergi
determin
skin
vitro
allergen
test
diagnosi
nare
support
histori
physic
exam
examin
greater
eosinophilia
nasal
smear
lack
posit
vivo
vitro
allergi
test
conserv
treatment
includ
aforement
nonallerg
rhiniti
strategi
includ
avoid
aggrav
irrit
smoke
pollut
case
may
respond
exercis
head
bed
elev
nasal
alar
dilat
pharmacolog
treatment
nare
includ
topic
intranas
corticosteroid
budesonid
intranas
ipratropium
effect
reduc
symptom
rhinorrhea
occup
rhiniti
either
allerg
nonallerg
caus
allergen
irrit
respect
encount
workplac
exampl
substanc
induc
allerg
rhiniti
includ
anim
food
eman
deterg
contain
chlorin
ammonia
associ
nonallerg
occup
rhiniti
occup
asthma
may
accompani
rhiniti
diagnosi
occup
rhiniti
like
form
rhiniti
base
histori
physic
exam
ige
sensit
demonstr
vivo
vitro
test
vitro
test
prefer
pregnanc
nasal
allergen
challeng
use
determin
suspect
caus
symptom
would
usual
defer
postpartum
eosinophil
basophil
eosinophil
cation
protein
tryptas
biolog
marker
increas
nasal
lavag
follow
allergen
challeng
igedepend
sensit
ideal
treatment
occup
rhiniti
avoid
aggrav
substanc
caus
symptom
site
visit
may
benefici
diagnost
allow
plan
sitespecif
chang
addit
occup
safeti
health
administr
osha
requir
employ
keep
onsit
report
potenti
substanc
review
conserv
measur
fail
symptom
persist
intranas
corticosteroid
consid
decongest
oxymetazolin
pseudoephedrin
may
use
first
trimest
appropri
riskbenefit
ratio
see
discuss
concomit
use
intranas
corticosteroid
longterm
oxymetazolin
etiolog
druginduc
rhiniti
caus
varieti
differ
medic
includ
ace
inhibitor
alphareceptor
antagonist
phosphodiesteras
inhibitor
betablock
calcium
channel
blocker
aspirin
nonsteroid
antiinflammatori
drug
nsaid
exacerb
rhiniti
associ
aspirinexacerb
respiratori
diseas
phenotyp
asthma
associ
nasal
polyp
asthma
sever
intoler
nsaid
rhiniti
medicamentosa
develop
prolong
use
topic
alphaadrenerg
agent
oxymetazolin
phenylephrin
symptom
caus
hypertrophi
nasal
mucosa
loss
nasociliari
structur
goblet
cell
hyperplasia
subsequ
rebound
nasal
obstruct
repeat
use
medic
develop
littl
day
often
much
longer
interv
use
nasal
septal
perfor
result
complic
use
intranas
cocain
similarli
caus
rhiniti
medicamentosa
subject
may
develop
tachyphylaxi
need
frequent
dose
achiev
adequ
decongest
diagnosi
topic
druginduc
rhiniti
obtain
detail
histori
physic
examin
nasal
mucosa
appear
inflam
mucos
membran
ulcer
bleed
minim
mucu
especi
true
use
topicalintranas
adrenerg
agent
illicit
drug
use
rhiniti
associ
oral
medic
primarili
nasal
mucos
edema
nasal
congest
ideal
treatment
oral
druginduc
rhiniti
stop
medic
caus
problem
medic
primarili
caus
nasal
congest
discontinu
symptomat
therapi
variou
form
tri
manag
also
includ
elev
head
bed
nasal
dilat
use
intranas
corticosteroid
rhiniti
medicamentosa
treat
stop
offend
agent
use
intranas
corticosteroid
import
inform
subject
rhiniti
medicamentosa
symptom
may
worsen
temporarili
offend
agent
discontinu
short
burst
oral
corticosteroid
help
use
caution
due
potenti
risk
low
birth
weight
prematur
birth
preeclampsia
possibl
birth
defect
first
trimest
use
atroph
rhiniti
empti
nose
syndrom
caus
nasal
mucos
atrophi
result
nasal
eros
crust
blood
blood
clot
dryness
sometim
foul
odor
etiolog
primari
idiopath
atroph
rhiniti
unknown
howev
diseas
also
associ
recurr
chronic
infect
chronic
granulomat
diseas
tuberculosi
repeat
surgeri
radiat
therapi
secret
may
purul
superinfect
suspect
commonli
due
pseudomona
aeruginosa
staphylococcu
aureu
histori
physic
examin
essenti
make
diagnosi
nasal
mucos
membran
usual
dri
ulcer
cover
crusti
exud
nasal
caviti
may
appear
larger
usual
underli
bone
resorpt
nasal
septal
perfor
result
saddl
nose
deform
secondari
atroph
rhiniti
suspect
two
follow
criteria
present
subjectreport
recurr
epistaxi
episod
anosmia
cliniciandocu
nasal
purul
crust
presenc
chronic
inflammatori
diseas
sarcoidosi
granulomatosi
polyangi
churgstrauss
syndrom
two
sinonas
surgeri
diagnosi
clinic
computer
tomographi
ct
scan
may
help
evalu
subject
underli
system
diseas
nasal
biopsi
help
confirm
diagnosi
primari
distinguish
secondari
atroph
rhiniti
wherein
underli
diseas
treat
treatment
primari
atroph
rhiniti
consist
nasal
salin
wash
remov
crusti
exud
debri
nose
topic
mupirocin
secondari
infect
present
appropri
antibiot
mupirocin
studi
pregnanc
acut
chronic
rhinosinus
character
purul
rhinorrhea
postnas
discharg
anosmia
nasal
congest
facial
discomfort
headach
fever
cough
tabl
common
pregnanc
term
rhinosinus
indic
nose
sinus
affect
typic
infecti
rhiniti
secondari
viral
upper
respiratori
tract
infect
uri
preced
infecti
rhinosinus
associ
inflamm
nasal
caviti
sinus
classifi
base
symptom
durat
acut
rhinosinus
defin
symptom
last
less
week
subacut
rhinosinus
symptom
last
week
recurr
acut
rhinosinus
four
episod
rhinosinus
per
year
chronic
rhinosinus
symptom
last
greater
week
form
sinus
primarili
medic
surgic
problem
chronic
inflammatori
diseas
diagnosi
made
clinic
rhinoscopi
ct
scan
obtain
complic
surgeri
contempl
abnorm
ct
scan
confirm
diagnosi
mucos
thicken
air
fluid
level
occur
uri
take
sever
week
resolv
find
also
occur
allerg
rhiniti
rhinosinus
mucos
thicken
cyst
polyp
present
sinus
mostli
incident
find
etiolog
acut
rhinosinus
ar
classifi
base
etiolog
either
viral
bacteri
thu
term
acut
viral
rhinosinus
avr
acut
bacteri
rhinosinus
abr
respect
symptom
overlap
includ
list
avr
lead
abr
character
symptom
persist
day
object
confirm
purul
discharg
nare
posterior
pharynx
case
acut
rhinosinus
viral
origin
approxim
progress
abr
typic
caus
secondari
infect
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
staphylococcu
aureu
fig
diagnosi
ar
base
histori
physic
clinic
symptom
last
sever
week
less
consider
concern
individu
develop
secondari
bacteri
infect
manifest
fever
associ
purul
nasal
discharg
facial
discomfort
pain
usual
follow
viral
respiratori
tract
infect
rhinoscopi
may
necessari
confirm
diagnosi
indic
referr
subject
respond
antibiot
persist
fever
periorbit
edema
erythema
cranial
nerv
palsi
abnorm
extraocular
muscl
function
proptosi
vision
chang
sever
progress
headach
alter
mental
statu
sign
mening
inflamm
present
acut
rhinosinus
subacut
rhinosinus
similar
sole
differenti
durat
ill
treatment
avr
conserv
intranas
corticosteroid
budesonid
treatment
choic
doubleblind
control
studi
indic
efficaci
acut
viral
rhinosinus
intranas
decongest
oxymetazolin
may
also
use
nasal
mucosa
edema
prefer
first
trimest
use
temporarili
discontinu
unless
use
conjunct
intranas
corticosteroid
medic
antihistamin
oral
decongest
may
also
help
treatment
abr
similar
howev
antibiot
necessari
intranas
corticosteroid
plu
amoxicillin
amoxicillinclavulan
acid
secondor
thirdgener
cephalosporin
firstlin
drug
penicillinallerg
subject
macrolid
azithromycin
recommend
necessari
trimethoprimsulfamethoxazol
tmpsmx
particularli
penicillinallerg
subject
may
also
util
use
associ
folat
defici
mother
neural
tube
defect
newborn
durat
therapi
variabl
continu
subject
well
clear
discolor
nasal
discharg
day
sinu
punctur
salin
irrig
may
help
diagnos
treat
diseas
side
effect
may
help
reduc
discomfort
pain
main
complic
untreat
avr
progress
abr
complic
abr
includ
orbit
cellul
presept
periorbit
cellul
intracrani
epidur
abscess
osteomyel
surround
bone
mening
avr
usual
resolv
without
support
treatment
antihistamin
decongest
intranas
corticosteroid
etiolog
recurr
acut
rhinosinus
rar
diagnos
four
episod
abr
occur
year
resolut
symptom
infect
symptom
rar
similar
abr
diagnosi
made
clinic
nasal
endoscopi
occasion
imag
studi
consid
rule
underli
abnorm
soft
tissu
boney
structur
could
predispos
rar
boni
abnorm
ostiomeat
complex
sinu
caviti
uncommon
treatment
rar
ident
abr
addit
underli
etiolog
must
rule
variou
form
rhiniti
particularli
allerg
rhiniti
may
predispos
type
rhinosinus
one
studi
indic
chronic
use
antibiot
intranas
corticosteroid
benefici
reduc
number
episod
per
year
subject
recurr
acut
rhinosinus
evalu
primari
secondari
immunodefici
predispos
ill
cystic
fibrosi
ciliari
dysfunct
anatom
abnorm
referr
compet
allergistimmunologist
help
purpos
chronic
rhinosinus
cr
inflammatori
condit
involv
paranas
sinus
last
month
may
begin
acut
viral
respiratori
tract
infect
fail
resolv
symptom
sign
vari
preval
sever
includ
nasal
congest
anterior
posterior
mucopurul
discharg
facial
discomfort
pressur
full
headach
olfactori
disturb
fatigu
malais
cough
sleep
disturb
also
present
subtyp
cr
includ
cr
nasal
polyposi
cr
np
cr
without
nasal
polyposi
cr
without
np
allerg
fungal
rhinosinus
afr
mucos
remodel
occur
occur
sever
asthma
potenti
result
irrevers
chronic
upper
airway
diseas
presenc
two
symptom
sign
greater
month
suggest
cr
includ
mucopurul
discharg
nasal
obstruct
congest
facial
pain
pressur
full
face
decreas
sens
smell
also
ideal
requir
document
inflamm
mean
one
follow
purul
discharg
edema
middl
meatu
anterior
ethmoid
region
rhinoscopi
nasal
polyp
rhinoscopi
radiograph
imag
consist
clinic
diagnosi
chronic
sinus
subject
chronic
sinus
particularli
associ
chronic
infect
evalu
primari
secondari
immunodefici
predispos
ill
cystic
fibrosi
ciliari
dysfunct
anatom
abnorm
referr
compet
allergistimmunologist
help
purpos
cr
nasal
polyposi
cr
np
cr
np
account
cr
character
presenc
nasal
polyp
usual
eman
middl
meatu
gradual
worsen
nasal
congest
feel
full
pressur
face
anterior
posterior
pharyng
purul
drainag
anosmia
fever
facial
discomfort
usual
absent
transluc
yellowgray
white
often
glisten
polyp
usual
visibl
anterior
rhinoscopi
edemat
nasal
turbin
often
mistaken
polyp
former
pink
sensit
touch
appear
similar
surround
mucosa
cr
without
nasal
polyposi
cr
without
np
cr
without
np
common
form
cr
account
approxim
case
differenti
cr
without
np
rar
may
difficult
former
persist
latter
intermitt
symptom
sign
symptom
sign
includ
facial
full
discomfort
pain
anteriorposterior
purul
chang
fatigu
elev
temperatur
rare
pathophysiolog
diseas
complet
understood
allerg
fungal
rhinosinus
afr
account
cr
usual
caus
colon
mucos
membran
upper
airway
sinus
noninvas
fungu
common
aspergillu
fumigatu
subsequ
allerg
respons
subject
afr
often
asthma
np
allerg
rhiniti
occur
immunocompet
subject
sign
symptom
similar
cr
np
subject
afr
howev
usual
pathognomon
peanut
butter
appear
mucu
drainag
nare
posteriorli
oral
pharynx
appropri
treatment
cr
reduc
sign
symptom
diseas
improv
qualiti
life
primarili
involv
control
mucos
inflamm
edema
improv
sinu
tract
ventil
drainag
treat
microorgan
involv
tri
reduc
frequenc
exacerb
accomplish
rule
underli
immunodefici
diseas
treat
underli
allerg
diseas
present
administ
appropri
immun
medic
manag
cr
typic
involv
topic
corticosteroid
reduc
inflamm
antibiot
treat
offend
microorgan
nasal
irrig
promot
sinu
drainag
system
corticosteroid
sometim
indic
decreas
inflamm
usual
short
period
time
evidencebas
medicin
lack
form
treatment
intranas
corticosteroid
budesonid
versu
system
corticosteroid
prefer
especi
pregnanc
indic
antibiot
regimen
amoxicillinclavulan
acid
usual
first
drug
choic
other
includ
macrolid
erythromycin
clindamycin
metronidazol
although
latter
medic
contraind
first
trimest
antibiot
consid
includ
cefuroxim
cefdinir
cefpodoxim
azithromycin
tmpsmx
penicillinallerg
antifung
proven
help
sometim
util
howev
shown
safe
use
pregnanc
allerg
diseas
form
rhiniti
rhinosinus
affect
approxim
onethird
women
childbear
age
poorli
control
affect
qualiti
life
could
potenti
harm
mother
fetu
therefor
requir
proper
diagnosi
effect
treatment
sleepdisturb
breath
one
common
symptom
report
untreat
rhiniti
rhinosinus
pregnant
nonpregn
subject
sequela
includ
gener
malais
cognit
psychiatr
problem
impair
exercis
toler
decreas
selfesteem
depress
decreas
work
product
specif
among
pregnant
subject
suffer
diseas
qualiti
life
third
versu
second
trimest
appear
wors
